Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FuelCell Energy Inc (FCEL) vs Viatris Inc (VTRS) Price & Performance

FuelCell Energy IncTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

FuelCell Energy Inc vs Viatris Inc — how do they compare? FuelCell Energy Inc trades at $19.29 (market cap $1.59B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Viatris Inc is far larger — about 11.8× FuelCell Energy Inc's market cap, and Viatris Inc pays a 2.95% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals.

FCELVTRS
Market Cap
$1.59B$18.69B
Sector
IndustrialsHealth
52-Week High
$36.01$17.86
52-Week Low
$3.92$9.49
Enterprise Value
$1.43B$30.81B
Dividend Yield
2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FuelCell Energy Inc

FCEL trades at $20.43, up 0.54% today, near the analyst consensus target of $20.75. The stock shows a bearish technical signal with negative moving averages, while fundamentals reveal persistent losses: revenue grew to $158.16M in 2025 but net income margin was -132.41%. Recent news highlights partnerships with Siemens and AI data center demand as growth catalysts, though cash flow from operations remains negative at -$125.29M.

FCEL presents high-risk growth potential driven by alternative energy tailwinds and strategic alliances, but investment is speculative due to unprofitability, cash burn, and competitive pressures. Analysts are split evenly between Buy and Hold ratings, reflecting cautious optimism amid financial challenges. The stock's outlook hinges on execution toward profitability and scaling commercial projects.

Viatris Inc

Viatris (VTRS) trades at $16.43, up 0.86% with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $0.69, exceeding expectations, with revenues rising 5% year-over-year. However, fundamental challenges persist with negative net income margin (-2.79%) and elevated P/E ratio (236.2). Recent developments include FDA approval for Gwyn Lo contraceptive patch and strategic divestitures to sharpen focus.

While Viatris shows operational improvements with consistent cash flow generation, the stock faces headwinds from profitability challenges and high valuation multiples. The mixed analyst sentiment (30.77% buy rating) reflects uncertainty about the company's turnaround trajectory. Key risks include ongoing margin pressure and competitive threats in the generic pharmaceutical space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About FuelCell Energy Inc

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.

Read more on FCEL

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS